Dr. Alfonso is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Clinical Research Building, Room 1129
1120 NW 14 Street
Miami, FL 33136Phone+1 305-243-5554Fax+1 305-243-1731
Summary
- Dr. Carlos Alfonso is a cardiologist in Miami, FL and is affiliated with multiple hospitals in the area, including University of Miami Hospital, Miami Veterans Affairs Healthcare System, Jackson Health System, and University of Miami Hospital and Clinics. He received his medical degree from University of Miami Miller School of Medicine and has been in practice 15 years specializing in interventional and structural cardiology. He is the Medical Director of the complex PCI and CTO program at the University of Miami UHealth Towers with experience in CHIP percutaneous coronary intervention and complex coronary disease including CTO and high-risk interventions with mechanical circulatory support and shock. He also performs structural and valvular heart interventions including transcatheter aortic replacement (TAVR), percutaneous mitral valve therapies (TEER).
Education & Training
- University of Miami/Jackson Health SystemFellowship, Interventional Cardiology, 2008 - 2009
- University of Miami/Jackson Health SystemFellowship, Cardiovascular Disease, 2005 - 2008
- University of Miami/Jackson Health SystemResidency, Internal Medicine, 2002 - 2005
- University of Miami Leonard M. Miller School of MedicineClass of 2002
Certifications & Licensure
- FL State Medical License 2008 - 2026
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Allogeneic Mesenchymal Human Stem Cell Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects With Symptomatic Ischemic Heart Disease. (ACESO-IHD) Start of enrollment: 2021 Aug 16
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 241 citationsRandomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM TrialJoshua M. Hare, Darcy L. DiFede, Angela C. Rieger, Victoria Florea, Ana Marie Landin
Journal of the American College of Cardiology. 2017-02-07 - 33 citationsBalloon mitral valvuloplasty in the United States: a 13-year perspective.Apurva Badheka, Neeraj Shah, Abhijit Ghatak, Nileshkumar J. Patel, Ankit Chothani
The American Journal of Medicine. 2014-11-01 - 101 citationsInitial Findings From the North American COVID-19 Myocardial Infarction Registry.Santiago Garcia, Payam Dehghani, Cindy L. Grines, Laura Davidson, Keshav R. Nayak
Journal of the American College of Cardiology. 2021-04-27
Lectures
- Core Curriculum: Valvular Heart Disease in the Percutaneous Era2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
- Panel Discussion Moderator2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
- Debate: Multi-vessel PCI in STEMI and Shock I Don't Care What the Data Says This Maybe the Patient's Only Chance!2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
Authored Content
- Weekend Summary from the AHA 2023 Scientific SessionsNovember 2023
Press Mentions
- New Technologies Offer UHealth Interventional Cardiologists Greater Precision, Improved Patient SelectionMay 8th, 2023
Professional Memberships
- Fellow
- Member
- Society of Cardiac Angiography and InterventionsFellow
Other Languages
- Spanish
External Links
- Umiamihealth.orghttps://doctors.umiamihealth.org/provider/Carlos+E+Alfonso/525391
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: